Mode
Text Size
Log in / Sign up
N/A N=487 Randomized Single-blind Health Services Research

The SUCCEED Trial of Secondary Stroke Prevention

Stroke · Secondary Stroke Prevention

Enrolled (actual)
487
Serious AEs
0.0%
Results posted
Nov 2019
Primary outcome: Primary: Systolic Blood Pressure — 133.1; 136.9 mm Hg — p=0.73

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Care Management+Community Health Worker (Behavioral); Usual Care (Behavioral)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
University of California, Los Angeles
Primary completion
Sep 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Systolic Blood Pressure
133.1; 136.9 0.73
SECONDARY
Dyslipidemia
98.7; 104.1 0.77
SECONDARY
Percentage of Glycated Hemoglobin (Hemoglobin A1C)
6.5; 6.6
SECONDARY
Inflammation: C-reactive Protein
1.1; 1.2 0.002 sig
SECONDARY
Body Mass Index
29.5; 29.2 0.86
SECONDARY
Waist Circumference
102.9; 101.4 0.10
SECONDARY
Physical Activity
1251; 1344 0.46
SECONDARY
Salt Intake
181; 168; 27; 34; 33; 44 0.011 sig
SECONDARY
Soda Intake
107; 102; 99; 99; 35; 45 0.47
SECONDARY
Fruit and Vegetable Intake
22; 28; 184; 172; 35; 46 0.58
SECONDARY
Smoking
25; 22; 182; 181; 34; 43 0.74
SECONDARY
Knowledge About Stroke Signs
95; 65; 69; 75; 28; 40 0.0021 sig
SECONDARY
Knowledge About Stroke Risk Factors
54; 49; 154; 155; 33; 42 0.07
SECONDARY
Patient Perception of Quality of Stroke Preventative Care
126; 91; 30; 42; 36; 55 0.32
SECONDARY
Vascular Events
26; 29; 194; 196 0.77
SECONDARY
Medication Adherence - Global
148; 150; 31; 27; 2; 1 0.20
SECONDARY
Medication Adherence - Blood Pressure Medication
91.6; 89.4 0.45
SECONDARY
Medication Adherence - Cholesterol Medication
86.7; 87.1 0.93
SECONDARY
Medication Adherence - Antithrombotic Medication
88.5; 89.4 0.80
SECONDARY
Medication Adherence - Antidepressant Medication
87.8; 96.2 0.25

Summary

The purpose of this study is to test a newly-developed outpatient clinic and community-based care intervention called SUCCEED (Secondary stroke prevention by Uniting Community and Chronic care model teams Early to End Disparities) for improving control of stroke risk factors among stroke patients in the Los Angeles County "safety net", and to measure the costs of running such an intervention, relative to usual care.

Eligibility Criteria

Inclusion Criteria

  • Patients of Los Angeles County+University of Southern California (LAC-USC), Rancho Los Amigos, Olive View-University of California, Los Angeles (UCLA), or Harbor-UCLA
  • Transient ischemic attack (TIA), ischemic stroke or hemorrhagic stroke within the prior 90 days
  • English, Spanish, Korean, Mandarin or Cantonese-speaking
  • 40 years of age or older
  • Capable of giving informed consent (no proxies will be used to obtain consent)
  • Systolic blood pressure is 130 mm Hg or greater OR Systolic blood pressure is between 120 mm Hg and 130 mm Hg and there is diagnosed/treated hypertension prior to the stroke or TIA

Exclusion Criteria

  • Younger than 40 years
  • Systolic Blood Pressure less than 120 mm Hg OR systolic blood pressure is between 120 mm Hg and 130 mm Hg and there is no known history of hypertension prior to the stroke or TIA
  • Speaks language other than English, Spanish, Korean, Mandarin, and Cantonese
  • Inability to comprehend the study because of communication or cognitive impairments
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01763203). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search